Predictors of first ischemic lower limb ulcer in dialysis patients: an observational cohort study

J Nephrol. 2018 Jun;31(3):435-443. doi: 10.1007/s40620-017-0429-3. Epub 2017 Aug 22.

Abstract

Background: Lower limb ischemia affects the quality of life, physical activity and life expectancy of dialysis patients. The aim of this study was to investigate the risk factors associated with ischemic foot ulcers considering clinical, laboratory and therapeutic domains.

Methods: This observational cohort study was based on data from the Nephrology and Dialysis Department database of Alessandro Manzoni Hospital, Lecco (Italy). All of the incident patients who started dialysis between 1 January 1999 and 29 February 2012 were enrolled, excluding temporary guests, patients with acute renal failure and patients with previous limb ischemia or amputation. Multivariate Cox regression analysis identified the predictors in each domain, which were matched in the final model. A time-dependent approach was used to take into account the evolution of some of the prognostic covariates.

Results: Of the 526 incident dialysis patients, 120 developed a lower limb ischemic lesion after a median of 13 months. The incidence of new ulcers was constant during the study period (6 per 100 person-years), but higher in the diabetics with a relative rate of 4.5. The variables significantly related to an increased risk of lower limb ulcers were age, male gender, diabetes, ischemic heart disease, treatment with proton pump inhibitors, iron, anticoagulants and calcium-based binders, and blood levels of phosphorus, triglycerides and C-reactive protein.

Conclusion: The incidence of lower limb ulcers was highest during the early dialysis follow-up and was associated with, in addition to diabetes, modifiable laboratory and therapeutic predictors such as anticoagulants, proton pump inhibitors, calcium-containing binders, calcimimetics and iron.

Keywords: Anticoagulants; Chronic renal failure; Diabetes; Iron; Ischemic ulcers; Phosphate binders.

Publication types

  • Observational Study

MeSH terms

  • Age Factors
  • Aged
  • Anticoagulants / therapeutic use
  • C-Reactive Protein / metabolism
  • Calcimimetic Agents / therapeutic use
  • Diabetes Mellitus / epidemiology
  • Dietary Supplements
  • Female
  • Foot Ulcer / epidemiology*
  • Foot Ulcer / etiology
  • Humans
  • Incidence
  • Iron / therapeutic use
  • Ischemia / epidemiology*
  • Ischemia / etiology
  • Male
  • Middle Aged
  • Myocardial Ischemia / epidemiology
  • Peritoneal Dialysis
  • Phosphorus / blood
  • Proportional Hazards Models
  • Protective Factors
  • Proton Pump Inhibitors / therapeutic use
  • Renal Dialysis* / adverse effects
  • Risk Factors
  • Sex Factors
  • Vitamin D / therapeutic use

Substances

  • Anticoagulants
  • Calcimimetic Agents
  • Proton Pump Inhibitors
  • Vitamin D
  • Phosphorus
  • C-Reactive Protein
  • Iron